Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia

Clinical trial NCT06695741 · RECRUITING

Trial details

NCT number: NCT06695741
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia Cyclophosphamide Reduced-dose Immunosuppressive Therapy

Start date: 2024-11-01
Primary completion: 2027-02-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.